Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-26

Clinical Trial Update: Escitalopram in Asthma Patients With Frequent Exacerbation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating escitalopram for asthma patients with frequent exacerbations and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lexapro (escitalopram)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Asthma | Phase 2 | Status: RECRUITING